The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 14,226 | 2,694,295 | SH | SOLE | 2,694,295 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 7,225 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| APPLIED GENETIC TECHNOLOGIES | COM | 03820J100 | 4 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 33,937 | 2,797,744 | SH | SOLE | 2,797,744 | 0 | 0 | ||
| ANGION BIOMEDICA CORP | COM | 03476J107 | 2,901 | 222,836 | SH | SOLE | 222,836 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 6,174 | 762,183 | SH | SOLE | 762,183 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 13,321 | 3,076,376 | SH | SOLE | 3,076,376 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,447 | 1,211,286 | SH | SOLE | 1,211,286 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 5,255 | 218,951 | SH | SOLE | 218,951 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 7,620 | 6,626,085 | SH | SOLE | 6,626,085 | 0 | 0 | ||
| CONTRAFECT CORP | COM NEW | 212326300 | 296 | 67,208 | SH | SOLE | 67,208 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 32,022 | 6,770,000 | SH | SOLE | 6,770,000 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 125 | 46,886 | SH | SOLE | 46,886 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 19,081 | 7,632,530 | SH | SOLE | 7,632,530 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 1,869 | 419,942 | SH | SOLE | 419,942 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,732 | 303,851 | SH | SOLE | 303,851 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 2,843 | 443,507 | SH | SOLE | 443,507 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 3,265 | 517,445 | SH | SOLE | 517,445 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,792 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NEUBASE THERAPEUTICS INC | COM | 64132K102 | 149 | 31,070 | SH | SOLE | 31,070 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 7,820 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 9,818 | 3,305,617 | SH | SOLE | 3,305,617 | 0 | 0 | ||
| SCYNEXIS INC | COM NEW | 811292200 | 1 | 100 | SH | SOLE | 100 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 2,541 | 169,542 | SH | SOLE | 169,542 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 5,611 | 165,041 | SH | SOLE | 165,041 | 0 | 0 | ||
| YUMANITY THERAPEUTICS INC | COM | 98872L102 | 5,149 | 441,959 | SH | SOLE | 441,959 | 0 | 0 | ||